About Wolfgang Hofmann
Wolfgang Hofmann is a board member, trailhead biosystems at Trailhead Biosystems.
Experience
This experience comes from Wolfgang Hofmann's profile and from SEC filings. For roles taken from filings, the years are when the filings name Wolfgang Hofmann in the role, so the role may have started earlier or lasted longer.
EV
Evotec Current
Supervisory Board Member
2026 – Present
LN
leon-nanodrugs Current
Chief Executive Officer
2025 – Present
Trailhead Biosystems Inc. Current
Board Member, Trailhead Biosystems
Non-Executive Director (2024 – Present)
2024 – Present · Beachwood, OH
Human cell products for drug discovery and cell therapy research.
FG
Fresenius Group
Group Head of Technology and Innovation
2021 – 2024
FC
Fresenius Medical Care
Global Head of Mergers & Acquisitions (2010 – 2021)
VP, Pharmaceuticals (2006 – 2010)
2006 – 2021
AG
ANM Adaptive Neuromodulation GmbH
Founder, Investor & Board Member (Non-Exec.)
2005 – 2012
NO
Novartis
Various roles in Sales, Marketing, Development, Corp. VC, M&A in Pharma, MedTech & Consumer Health
1999 – 2005
DI
Dana-Farber Cancer Institute
Research Fellow
1995 – 1999
UT
University of Tuebingen
House Officer
1995
Key Colleagues at Startups
The people Wolfgang Hofmann works with at each company, as listed on that company's latest Form D.
Trailhead Biosystems Inc. · Form D/A, Jul 30, 2026
HH
Houman Hemmati
Director
Craig Nemiroff
Managing Director, MAK Capital
David Llewellyn
President and Chief Executive Officer, director
Joshua Snow
Chief Commercial Officer
Jan Jensen
Board Member, Trailhead Biosystems
Divya Trivedi
Chief Operating Officer
Michael Kaufman
Chief Executive Officer, MAK Capital and director